AB US Research Advanced ETF Current Cash

AB US Research Advanced ETF (RADD) currently reports a current cash of $7.1M as of June 2026. That compares with $1M in the prior-year period — up 588.2% year over year. Use the charts on this page to explore AB US Research Advanced ETF's current cash history and peer comparisons.

AB US Research Advanced ETF's current cash increased from $1M to $7.1M — a 588.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AB US Research Advanced ETF reported $7.1M in current cash as of June 2026. That compares with $1M in the prior-year period — up 588.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $7.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AB US Research Advanced ETF, and consider following RADD for alerts when major investors trade the stock.

AB US Research Advanced ETF is classified in the Healthcare sector. On current cash, it currently shows $7.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RADD with unrelated industries.